本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

3.57
-0.2900-7.51%
成交量:106.04万
成交额:385.80万
市值:2.55亿
市盈率:-2.13
高:3.88
开:3.88
低:3.48
收:3.86
52周最高:4.05
52周最低:0.7830
股本:7,130.85万
流通股本:5,355.59万
量比:0.75
换手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-1.6773
每股收益(LYR):-1.9732
净资产收益率:-48.56%
总资产收益率:-30.23%
市净率:1.22
市盈率(LYR):-1.81

数据加载中...

2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities